Xibrom
INDICATIONS
XIBROM ophthalmic solution is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.
DOSAGE AND ADMINISTRATION
For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of XIBROM ophthalmic solution should be applied to the affected eye(s) two times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period.
HOW SUPPLIED
XIBROMÃ? (bromfenac ophthalmic solution) 0.09% is supplied in a white LDPE plastic squeeze bottle with a 15 mm LDPE white dropper-tip and 15 mm polypropylene gray cap as follows:
| NDC 67425-004-50 | 5 mL in 10 cc container |
Storage
Store at 15-25 C (59-77° F)
Manufactured for: ISTA Pharmaceuticals, Inc., Irvine, CA 92618
by: Bausch & Lomb Incorporated, Tampa, FL 33637
Under license from: Senju Pharmaceutical Co., Ltd., Osaka, Japan 541-0046
Issued Date: July 2005 Printed in USA COPYRIGHT © ISTA Pharmaceuticals, Inc. All rights reserved.
FDA revision date: 01/27/06
Generic Name: Bromfenac
WebMD Daily
Get breaking medical news.
Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »
Xibrom
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.